Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New ultrasound device aims to tighten sagging chin and neck without surgery

NCT ID NCT07229430

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called ULTRAFORMER MPT PLUS that uses focused ultrasound to lift and tighten loose skin under the chin and on the neck. About 273 adults with mild to moderate skin laxity will receive either the new device or an approved one. Researchers will check results using photos and patient feedback over 90 days.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 273 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2025

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

30 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Male or female subjects aged 30 to 65 years, inclusive, at the time of informed consent. 2. Subjects presenting with mild to moderate submental and/or neck skin laxity, as determined by the investigator. 3. Subjects in good general health with stable body weight (±5%) for at least 6 months prior to screening. 4. Subjects willing to avoid other aesthetic or dermatologic procedures (surgical or non-surgical) to the treatment area during the study period. 5. Subjects able to understand and sign informed consent and comply with all study visits and procedures. 6. Female subjects of child-bearing potential who agree to use reliable contraception throughout study participation. Exclusion Criteria: 1. Prior facelift, neck lift, liposuction, or contouring surgery involving the lower face, submental, or neck areas. 2. Receipt of any energy-based aesthetic treatment (e.g., HIFU, radiofrequency, laser) or injectable aesthetic treatment (e.g., botulinum toxin, dermal filler, collagen stimulator) to the treatment area within 6 months prior to baseline. 3. Presence of any implanted electronic medical device, such as a pacemaker, defibrillator, or neurostimulator. 4. Active skin infection, wound, cystic acne, inflammation, or severe scarring within or near the treatment area. 5. History of keloid formation or abnormal wound healing. 6. Known bleeding disorder, or use of anticoagulant or antiplatelet medications that cannot be safely discontinued for the procedure. 7. Pregnant or breastfeeding women. 8. Subjects with a known sensitivity or contraindication to ultrasound-based procedures. 9. Any medical or psychiatric condition that, in the investigator's judgment, could interfere with study participation, safety, or data integrity. 10. Participation in another investigational study within 30 days prior to screening.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Facial skin laxity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    5 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Dermatology

    RECRUITING

    Los Angeles, California, 90004, United States

  • Dermatology

    RECRUITING

    Charlotte, North Carolina, 28405, United States

  • Dermatology

    RECRUITING

    Wilmington, North Carolina, 28405, United States

  • Dermatology

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • Dermatology

    RECRUITING

    Spokane, Washington, 99204, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.